Security National Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Security National Trust’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$234K	Hold	2,500	–	–	0.05%	153
2021 Q2	$234K	Hold	2,500	–	–	0.05%	158
2021 Q1	$230K	Hold	2,500	–	–	0.05%	155
2020 Q4	$183K	Hold	2,500	–	–	0.05%	173
2020 Q3	$194K	Buy	+2,500	New	+$172K	0.05%	157

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Security National Trust's HZNP Position: Q3 2021 in Review

Security National Trust held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q3 2021 at 2,500 shares worth $234K. The position accounts for 0.05% of the portfolio, ranked #153.

Security National Trust first reported a position in HZNP in Q3 2020 and has held it in 5 quarters since. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

Security National Trust held 2,500 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $234K as of Q3 2021.
Security National Trust left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q3 2021.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.05% of Security National Trust's portfolio in Q3 2021, its #153 holding.
Security National Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and has held it in 5 quarters since.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.